Search
Dyne Therapeutics Inc
DYNAdd to Watchlist
17.160USD
+0.150+0.88%
Close 11-13 16:00（ET）
3.20BMarket Cap
LossP/E TTM
Dyne Therapeutics Inc (DYN) Stock Price Target & Forecast
Analyst Rating
Based on 17 analysts giving stock ratings to Dyne Therapeutics Inc in the past month.
Buy
6 Strong Buy
10 Buy
0 Hold
1 Sell
0 Strong Sell
Target Price
36.071USD+116.13%
DYN Analyst Recommendation Trends
In the current month, DYN has received 10 Buy Ratings, 0 Hold Ratings, and 1 Sell Ratings. DYN average Analyst price target in the last month is 36.071.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
6
6
6
6
6
6
6
6
10
10
10
9
8
8
8
8
0
0
1
2
2
2
2
2
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
0
17
17
17
17
16
16
16
16
Financial Forecasting
Based on analysts' estimates, DYN EPS is projected to reach -0.981 in FY2026Q4, following reported EPS of -1.065 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.77
-0.75
-0.91
-0.98
-1.01
Actual
-0.73
-1.08
-1.06
--
--
Surprise
+5.28%
-43.77%
-16.71%
--
--
FAQs
What is Dyne Therapeutics Inc's price target?
Analysts forecast that Dyne Therapeutics Inc's price target is USD 36.00, with the highest forecast at USD 50.00 and the lowest forecast at USD 9.00.
How have Dyne Therapeutics IncDYN's recent earnings per share performed?
The market expectation was USD -1.06, while Dyne Therapeutics IncDYN's earnings per share (EPS) for the previous quarter was USD -1.08. EPS for the next quarter is expected at USD -0.98.
What is the analyst rating for Dyne Therapeutics Inc?
Based on the ratings of Dyne Therapeutics Inc's stock from 17 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.